Phloridzin

• Anti-oxidant protection
• Anti-aging effects
• Blood glucose regulation
• Metabolic health support

• Neuroprotection
• Cardiovascular health support
• Anti-inflammatory effects
• Gut health improvement
• Potential cancer prevention

Phloridzin exerts its biological effects through multiple molecular mechanisms. Its primary and most well-documented mechanism is the inhibition of sodium-glucose cotransporter proteins (SGLTs), particularly SGLT1 in the intestine and SGLT2 in the kidneys. By competitively binding to these transporters, phloridzin blocks glucose reabsorption in the kidneys and reduces glucose absorption in the intestine, leading to decreased blood glucose levels and increased urinary glucose excretion. This mechanism has made phloridzin a model compound for the development of SGLT2 inhibitors used in diabetes treatment.

Beyond glucose transport inhibition, phloridzin exhibits potent antioxidant properties through direct scavenging of reactive oxygen species (ROS) and reactive nitrogen species (RNS). It also enhances endogenous antioxidant defense systems by activating nuclear factor erythroid 2-related factor 2 (Nrf2), which increases the expression of antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase. In Caenorhabditis elegans models, phloridzin has been shown to extend lifespan through DAF-16 (a FOXO transcription factor homolog) activation, which regulates stress response genes and autophagy pathways. This longevity effect appears to be mediated through multiple conserved pathways including insulin/IGF-1 signaling, TOR signaling, and germline signaling.

Phloridzin also exhibits anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB) activation and reducing the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). It suppresses the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), further reducing inflammatory mediator production. In metabolic regulation, phloridzin activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis, which improves insulin sensitivity, enhances fatty acid oxidation, and reduces lipogenesis. It also inhibits pancreatic α-amylase and intestinal α-glucosidase, enzymes involved in carbohydrate digestion, further contributing to its anti-hyperglycemic effects.

Phloridzin’s neuroprotective properties stem from its ability to reduce oxidative stress in neural tissues, inhibit neuroinflammation, and protect against amyloid-beta toxicity. It may enhance brain-derived neurotrophic factor (BDNF) levels, supporting neuronal health and plasticity. In cancer cells, phloridzin has been shown to induce cell cycle arrest and apoptosis through modulation of various signaling pathways including PI3K/Akt and MAPK/ERK. It inhibits glucose uptake in cancer cells by blocking glucose transporters (GLUTs), potentially starving cancer cells of their primary energy source.

Additionally, phloridzin exhibits antimicrobial properties against various pathogens through disruption of bacterial cell membranes and inhibition of bacterial enzymes. It also modulates gut microbiota composition, potentially contributing to its metabolic and anti-inflammatory effects.

There is no established standard dosage for phloridzin as a standalone supplement for general health purposes. Most research has been conducted using apple extracts containing phloridzin among other compounds, or in animal models using various doses. Based on preliminary research, typical supplemental doses range from 50-300 mg of phloridzin daily, though this is not well-established in human clinical trials.

For general health benefits, phloridzin can be taken with meals to improve tolerance. For blood glucose management, taking before meals may help reduce postprandial glucose spikes. Dividing the daily dose into two administrations (morning and evening) may provide more consistent effects throughout the day.

There is insufficient evidence to make specific recommendations about cycling phloridzin supplementation. For long-term use, consider periodic breaks (e.g., 1 week off after 8-12 weeks of supplementation) to prevent potential adaptation or tolerance development.

Taking with meals containing fat may enhance absorption. Avoid taking with high-sugar foods or beverages, as this may counteract some of the glucose-regulating benefits. Some evidence suggests that certain polyphenols in tea may enhance phloridzin’s effects.

Phloridzin has relatively low oral bioavailability, with absorption rates typically ranging from 2-8% of ingested amounts. This limited bioavailability is primarily due to its chemical structure, extensive first-pass metabolism, and degradation in the gastrointestinal environment. After oral administration, phloridzin is partially hydrolyzed by intestinal β-glucosidases to release phloretin (the aglycone form), which has better absorption characteristics but different biological activities.

Consumption with dietary fats: Taking phloridzin with a meal containing moderate fat content can enhance absorption by up to 30-40% by improving solubility and lymphatic transport., Micronization: Reducing particle size to micro or nano scale increases surface area and improves dissolution rates, potentially enhancing bioavailability by 50-100%., Liposomal formulations: Encapsulation in phospholipid bilayers can protect phloridzin from degradation in the gastrointestinal tract and enhance cellular uptake., Phytosome technology: Complexing with phospholipids creates a more lipid-compatible molecular complex that improves absorption across intestinal membranes., Co-administration with piperine: Black pepper extract can inhibit enzymes involved in phloridzin metabolism, potentially increasing bioavailability by 30-60%., Emulsion-based delivery systems: Oil-in-water emulsions can improve solubility and protect from degradation in the gastrointestinal environment., Cyclodextrin complexation: Forms inclusion complexes that protect phloridzin from degradation and improve solubility., Consumption with quercetin or other flavonoids: May compete for the same metabolic enzymes, potentially increasing phloridzin’s half-life and bioavailability.

For general health benefits, phloridzin-containing supplements are best taken with meals to maximize absorption. For blood glucose management, taking 15-30 minutes before meals may help modulate postprandial glucose response. Splitting the daily dose into two administrations (morning and evening) may provide more consistent blood levels throughout the day.

After absorption, phloridzin undergoes extensive phase I and phase II metabolism, primarily in the liver. The main metabolic pathways include deglycosylation (to form phloretin), glucuronidation, sulfation, and methylation. The resulting metabolites may retain some biological activity but often have different pharmacological profiles compared to the parent compound. Phloridzin and its metabolites are primarily excreted through urine and bile.

The plasma half-life of phloridzin is relatively short, typically 1-3 hours, although some metabolites may persist longer. Unabsorbed phloridzin reaches the colon where it is metabolized by gut microbiota into various phenolic acids, which may have their own biological activities and better absorption profiles.

Individual genetic variations in metabolizing enzymes, particularly β-glucosidases and UDP-glucuronosyltransferases, Age (generally lower bioavailability in older adults due to reduced intestinal absorption and hepatic metabolism), Gut microbiome composition, which affects the conversion of phloridzin to metabolites in the colon, Concurrent medications, particularly those affecting gastric pH or liver enzymes, Gastrointestinal health and transit time, Food matrix (whole foods vs. isolated compounds), Processing methods of source materials (heat treatment can reduce content), Storage conditions and age of supplement (degradation over time)

Phloridzin and its metabolites show preferential distribution to the kidneys, liver, and intestinal tissues, which aligns with its primary sites of action. Lower concentrations are found in the brain, suggesting limited blood-brain barrier penetration,

although some neuroprotective effects have been observed in animal studies. The compound and its metabolites can also be detected in adipose tissue, skeletal muscle, and the heart, though at lower concentrations compared to the primary target organs.

• Increased urinary glucose excretion (glycosuria) due to SGLT inhibition
• Potential hypoglycemia, especially when combined with diabetes medications
• Gastrointestinal discomfort (rare, typically at high doses)
• Mild diarrhea or loose stools (due to unabsorbed sugars in intestine)
• Increased urination frequency
• Electrolyte imbalances (rare, with prolonged high-dose use)
• Mild headache (uncommon)
• Temporary discoloration of urine (harmless)

• Diabetes (use with caution and medical supervision due to glucose-lowering effects)
• Kidney disease or impaired renal function (may exacerbate issues due to increased renal workload)
• History of urinary tract infections (increased risk due to urinary glucose)
• Hypotension (may enhance blood pressure-lowering effects)
• Pregnancy and lactation (insufficient safety data)
• Scheduled surgery (discontinue 2 weeks before due to potential glucose effects)
• Known allergy to apples or related fruits

• Antidiabetic medications (insulin, sulfonylureas, metformin): May enhance hypoglycemic effects, requiring dose adjustments
• Diuretics: May have additive effects on fluid balance and electrolyte levels
• Blood pressure medications: Potential additive hypotensive effects
• SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin): Redundant mechanism, may increase side effects
• Digoxin: Theoretical interaction due to potential electrolyte changes
• NSAIDs: May affect renal function when combined with phloridzin’s effects on the kidneys
• Corticosteroids: May counteract phloridzin’s glucose-lowering effects

No established upper limit for phloridzin specifically. Based on available research, doses up to 500 mg daily have been used in short-term studies without serious adverse effects. However, caution is advised with doses exceeding 300 mg daily, particularly in individuals with pre-existing health conditions or those taking medications.

Long-term safety data specific to phloridzin supplementation is limited. Most studies have been short-term (up to 12 weeks). Theoretical concerns with long-term use include potential kidney stress due to chronic glycosuria, electrolyte imbalances, and increased risk of urinary tract infections. Regular monitoring of kidney function and electrolyte levels is recommended for individuals using high doses long-term.

Acute toxicity studies in animal models have shown low toxicity. The LD50 (median lethal dose) in rodents is extremely high, indicating low acute toxicity risk. Genotoxicity studies have not shown mutagenic or clastogenic potential. Carcinogenicity studies have not indicated any cancer-promoting effects; in fact, evidence suggests potential anti-cancer properties.

Allergic reactions to phloridzin are rare but possible, particularly in individuals with existing apple allergies. Symptoms may include skin rash, itching, swelling, dizziness, or difficulty breathing. Discontinue use immediately if allergic reactions occur.

For individuals taking phloridzin supplements regularly, particularly at higher doses, periodic monitoring of the following is recommended: blood glucose levels, kidney function (eGFR, creatinine), electrolyte balance (particularly sodium and potassium), urinalysis (for signs of urinary tract infections), and blood pressure.

Phloridzin is not specifically approved as a pharmaceutical drug by the FDA. It falls under the category of dietary supplements regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994. As a dietary supplement ingredient, manufacturers cannot make specific disease treatment claims but can make structure/function claims with appropriate disclaimers. The FDA does not review or approve dietary supplements containing phloridzin before they enter the market.

Phloridzin from apple sources is generally recognized as safe (GRAS) when used in food products, as it is naturally present in apples and apple products that have a long history of safe consumption.

Eu: In the European Union, phloridzin is regulated under the European Food Safety Authority (EFSA) as a food constituent. As a supplement ingredient, phloridzin falls under the Food Supplements Directive (2002/46/EC). No approved health claims specific to phloridzin have been authorized by EFSA. Novel food applications would be required for phloridzin sources not traditionally consumed in the EU before May 1997, though apple extracts generally do not fall under this requirement.

Canada: Health Canada regulates phloridzin-containing supplements under the Natural Health Products Regulations. Products containing phloridzin must have a Natural Product Number (NPN) to be legally sold. Health Canada has not approved specific claims for phloridzin, though some general claims for apple polyphenols may be permitted. Phloridzin from traditional food sources is considered safe when used in appropriate amounts.

Australia: The Therapeutic Goods Administration (TGA) regulates phloridzin-containing supplements as complementary medicines. Products must be listed or registered on the Australian Register of Therapeutic Goods (ARTG). Traditional claims based on historical use may be permitted with appropriate evidence. Food Standards Australia New Zealand (FSANZ) oversees phloridzin when used as a food ingredient.

Japan: In Japan, phloridzin-containing supplements may be regulated as Foods with Health Claims, specifically as Foods with Functional Claims (FFC) if scientific evidence supports specific health benefits. Manufacturers must notify the Consumer Affairs Agency before marketing such products. Traditional food sources of phloridzin are generally permitted without specific regulation.

China: The China Food and Drug Administration (CFDA) regulates phloridzin-containing supplements. New ingredients may require extensive safety testing before approval. Traditional food sources of phloridzin that have a history of use in Chinese medicine may have different regulatory pathways.

Usa: Supplements containing phloridzin must be labeled as dietary supplements and include a Supplement Facts panel. Structure/function claims must be accompanied by the disclaimer: ‘This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.’ Manufacturers are responsible for ensuring that any claims are truthful and not misleading.

Eu: Products must be labeled as food supplements and include a Nutrition Facts panel. Any claims must comply with the Nutrition and Health Claims Regulation (EC) No 1924/2006. The term ‘apple polyphenols’ is more commonly used on labels than specific compounds like phloridzin.

General: Most jurisdictions require listing of all ingredients, appropriate storage conditions, expiration dates, and manufacturer contact information. Allergen information must be provided if relevant (e.g., if the product contains other apple components that might trigger apple allergies).

Disease treatment claims are prohibited in most jurisdictions without pharmaceutical approval. Claims regarding diabetes treatment or prevention are particularly scrutinized and generally not permitted for supplements. Structure/function claims must be supported by scientific evidence, though the standard of evidence varies by country. In the EU, health claims are more strictly regulated and must be pre-approved based on substantial scientific evidence.

Claims regarding children’s health are generally more restricted across all jurisdictions. Anti-aging and longevity claims are scrutinized carefully by regulatory authorities.

Cross-border trade of phloridzin-containing supplements may be subject to varying regulatory requirements. Products compliant in one jurisdiction may not meet the requirements of another. Some countries require pre-market registration or notification for imported supplements. Customs documentation should clearly identify the nature of the product and its ingredients.

Increasing regulatory focus on quality control and standardization of botanical extracts containing compounds like phloridzin. Growing interest in personalized nutrition may lead to more nuanced regulatory approaches for different population groups. Potential for more specific health claims as research evidence accumulates. Increasing harmonization of regulations across major markets to facilitate international trade.

Greater scrutiny of glucose-modulating supplements due to their potential interaction with diabetes medications.

While phloridzin itself is not approved as a pharmaceutical,

it served as the prototype for the development of synthetic SGLT2 inhibitors now approved for diabetes treatment (e.g., dapagliflozin, empagliflozin).

These medications were designed to overcome phloridzin’s limitations, including poor oral bioavailability and non-selective inhibition of both SGLT1 and SGLT2.

This pharmaceutical development history may influence how regulatory bodies view phloridzin supplements, particularly regarding marketing claims related to blood glucose management.

Medium to High

Pure phloridzin supplements are relatively rare in the market. Most supplements contain apple extracts standardized to contain specific percentages of phloridzin along with other polyphenols. For standardized apple extracts (typically 5-10% phloridzin), the cost ranges from $0.75 to $2.50 per effective daily dose. Enhanced bioavailability formulations (liposomal, phytosomal) typically cost $2.00 to $5.00 per effective daily dose.

Apple peel or bark extracts containing phloridzin range from $0.50 to $1.50 per effective daily dose, but may have lower standardization.

The cost-effectiveness of phloridzin supplementation depends largely on the specific health goals and individual factors. For general antioxidant support, less expensive apple polyphenol blends may provide adequate value. For specific metabolic applications requiring higher bioavailability, premium formulations may offer better value despite higher costs. Whole food sources (apples, particularly the peels) provide the most cost-effective way to consume phloridzin along with complementary compounds, though exact dosing is less precise and concentrations are much lower than in supplements.

The relatively short half-life of phloridzin means that consistent, regular supplementation is necessary for ongoing benefits, which should be factored into long-term cost considerations. Enhanced bioavailability formulations may ultimately provide better value despite higher upfront costs due to improved absorption and utilization.

Price Trends: Prices for apple extracts containing phloridzin have generally remained stable over the past decade, with slight increases due to growing demand for polyphenol supplements. Premium formulations with enhanced bioavailability continue to command higher prices. Seasonal variations affect the cost of raw materials, particularly for apple-derived extracts.

Regional Variations: Prices tend to be higher in North America and Europe compared to Asian markets. Local availability of apple sources significantly impacts regional pricing. Regulatory requirements in different regions affect production costs and final pricing.

Economy Of Scale: Bulk purchasing can significantly reduce costs, with discounts of 20-40% common for larger quantities. Subscription services often offer 10-15% discounts for regular purchases.

Purchase during seasonal sales, which can offer discounts of 15-30%, Consider bulk purchases for non-perishable forms, Subscribe to regular delivery services for consistent discounts, Combine dietary sources (apples with peels) with lower supplement doses, Focus on enhanced bioavailability formulations that may allow for lower effective doses, Look for combination products that provide synergistic compounds in a single formula, Consider apple peel powder as a more economical source, though standardization may be lower

Most health insurance plans do not cover phloridzin or apple polyphenol supplements. Some Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) may allow purchase of supplements with a doctor’s recommendation, though policies vary widely. Certain integrative medicine practitioners may prescribe specific formulations that could qualify for reimbursement under some plans.

Compared to other polyphenol supplements like quercetin or resveratrol, phloridzin supplements tend to be similarly priced or slightly more expensive. Compared to pharmaceutical SGLT2 inhibitors used for diabetes, phloridzin supplements are significantly less expensive but also less potent and specific for glucose control. For general antioxidant support, other options like vitamin C or mixed tocopherols may provide better value,

while phloridzin offers more specific benefits for glucose metabolism and certain longevity pathways.

Phloridzin and phloridzin-containing supplements typically have a shelf life of 18-24 months when properly stored. However, degradation begins immediately after production, with approximately 5-15% loss of active content per year under optimal storage conditions.

Store in airtight, opaque containers to protect from light, oxygen, and moisture. Refrigeration (2-8°C) is recommended to slow degradation, particularly after opening. Freezing (-18°C or below) can further extend stability for long-term storage. Avoid temperature fluctuations, which can accelerate degradation through condensation cycles. Keep away from strong-smelling substances as phloridzin can absorb odors that may affect sensory properties.

Color change is a visible indicator of degradation, with phloridzin shifting from pale yellow to darker brown as it oxidizes. However, some degradation can occur without visible color change. Analytical methods like HPLC or spectrophotometry are more reliable for quantifying remaining active content. Development of off-odors or flavors may indicate degradation or microbial contamination. Clumping or hardening of powder formulations suggests moisture exposure.

For powdered supplements, reconstituted solutions should be used within 24-48 hours and kept refrigerated. Stability in solution is significantly lower than in dry form. Acidification of the reconstitution liquid (e.g., with citric acid) can improve stability. Protection from light remains important after reconstitution.

Heat processing significantly reduces phloridzin content, with losses of 30-70% reported during cooking or pasteurization of apple products. Freeze-drying preserves more phloridzin than heat drying methods. Fermentation processes (as in cider production) can alter phloridzin content and convert it to other compounds. Mechanical processing that exposes the compound to oxygen (e.g., grinding, juicing) accelerates degradation unless antioxidant protection is provided.

Synthesis Methods

Natural Sources

Quality Considerations

Sustainability Considerations

Phloridzin has a fascinating history that spans traditional medicine, scientific discovery, and pharmaceutical development. While phloridzin itself was not specifically identified until the 19th century, apple tree bark, which contains high concentrations of the compound, has been used medicinally for centuries. In traditional European folk medicine, preparations from apple tree bark were used to treat fever, particularly the intermittent fevers associated with malaria. Native American tribes, including the Iroquois and Cherokee, used preparations from the inner bark of apple trees to treat various ailments, including digestive disorders and skin conditions.

The scientific history of phloridzin began in 1835 when it was first isolated from apple tree bark by French chemists. The name ‘phloridzin’ derives from the Greek words ‘phloios’ (bark) and ‘rhiza’ (root), reflecting its source in the bark and roots of apple trees. By the late 19th century, researchers had discovered that phloridzin administration caused glycosuria (glucose in the urine) in experimental animals. This observation led to its use as a research tool to study kidney function and glucose metabolism.

In 1886, Josef von Mering demonstrated that phloridzin could induce experimental diabetes in dogs by blocking glucose reabsorption in the kidneys, a landmark discovery in diabetes research. This ‘phloridzin diabetes’ became an important experimental model for studying diabetes before the discovery of insulin in 1921. Throughout the early 20th century, phloridzin was used extensively in physiological research to understand glucose transport mechanisms in the kidneys and intestine. These studies eventually led to the identification of the sodium-glucose cotransporter (SGLT) proteins that phloridzin inhibits.

In the pharmaceutical field, phloridzin served as the prototype for the development of synthetic SGLT2 inhibitors, a class of medications now widely used to treat type 2 diabetes. The first of these drugs, dapagliflozin, was approved in 2012, representing the culmination of research that began with phloridzin nearly 200 years earlier. In traditional apple cultivation, farmers and orchardists observed that apple trees with damaged bark often produced sweeter fruit. This phenomenon, now understood to be related to altered carbohydrate metabolism due to phloridzin loss from the damaged bark, influenced grafting and cultivation practices.

In the realm of natural medicine, apple cider vinegar, which contains trace amounts of phloridzin and related compounds, has a long history of use for blood sugar management, though the concentrations are much lower than those found in bark extracts. Modern interest in phloridzin as a dietary supplement began in the late 20th century with the growing focus on polyphenols and their potential health benefits. Research into its antioxidant, anti-inflammatory, and metabolic effects has expanded significantly in the 21st century, with particular attention to its potential role in healthy aging and longevity, as demonstrated in model organisms like C. elegans.

Meng, S., et al. (2020). Apple polyphenols and their health benefits: A comprehensive review. Critical Reviews in Food Science and Nutrition, 60(13), 2200-2211., Williamson, G., et al. (2018). Dietary polyphenols: A new strategy for the prevention and treatment of type 2 diabetes? Molecular Nutrition & Food Research, 62(1), 1700976.

NCT04255069: Effects of Apple Polyphenols on Glucose Metabolism in Pre-diabetic Individuals, NCT03865355: Apple Polyphenol Extract Supplementation and Cognitive Function in Older Adults, ISRCTN72366225: Phloridzin-enriched Apple Extract for Improving Metabolic Health in Overweight Adults

Limited human clinical trials specifically examining isolated phloridzin rather than apple extracts containing multiple compounds, Insufficient dose-response studies to establish optimal therapeutic dosages in humans, Limited long-term safety and efficacy data beyond 12 weeks of supplementation, Incomplete understanding of interactions with medications and other supplements, Need for bioavailability studies comparing different delivery systems, Limited research on genetic factors affecting individual responses to phloridzin supplementation, Insufficient data on phloridzin’s effects in specific populations such as the elderly or those with existing health conditions